chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tightness in her chest,sore in chest; skin rash; Welts at injection site; headache; muscle pain at injection site; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (muscle pain at injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), CHEST DISCOMFORT (tightness in her chest,sore in chest) and RASH (skin rash) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced HEADACHE (headache), MYALGIA (muscle pain at injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site). On 25-Jan-2021, the patient experienced CHEST DISCOMFORT (tightness in her chest,sore in chest), RASH (skin rash) and INJECTION SITE INFLAMMATION (Welts at injection site). At the time of the report, HEADACHE (headache), MYALGIA (muscle pain at injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), CHEST DISCOMFORT (tightness in her chest,sore in chest), RASH (skin rash) and INJECTION SITE INFLAMMATION (Welts at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Vaccine expired on 01 Apr 2022 and stored in refrigerator on 13 Apr 2022 around 8 PM; Received expired booster dose beyond MFG expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired booster dose beyond MFG expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 01 Apr 2022 and stored in refrigerator on 13 Apr 2022 around 8 PM) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired booster dose beyond MFG expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 01 Apr 2022 and stored in refrigerator on 13 Apr 2022 around 8 PM). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired booster dose beyond MFG expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 01 Apr 2022 and stored in refrigerator on 13 Apr 2022 around 8 PM) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that the patient received expired 1st booster dose. Vial was initially stored in the refrigerator on 13 April 2022 around 8PM and the vial did not undergo any temperature excursions.   No treatment details were reported.   This case was linked to MOD-2022-543469 (Patient Link).
It was reported that a 73 year old adult female, received dose of Fluzone (lot # U0879AA) IM in the right arm and Pneumovax 23 (lot # 0923L) IM in the left arm on 10/18/03. The patient developed weakness in her right hand with difficulty grasping. The right hand grasp was reported weaker than the left hand. Additionally, she experienced soreness in upper arm after injection was given and the soreness has increased over the last two weeks. No site swelling or redness was reported. The patient treated with Tylenol and warm compresses to the upper arm. Per the reporting nurse, the physician feels this isn't related to the dose of Fluzone received. A copy of this report was submitted by the reporter.
Flu vaccine given on 10/15/13 at nurse visit. Arm pain, itching and swelling. No other symptoms. No infection present. Advised to use BENADRYL or CLARITIN for histamine response.
Patient was admitted to Hospice on 8/11/20.  He experienced normal progression of his diseases until his death on 3/9/21.
This spontaneous report was received from a mother regarding her 5 year old son. Pertinent medical history or drug reaction/allergies were not provided. On an unknown date, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent)(manufacturer unknown) (dose, lot number and expiration date were not provided). Other suspect therapies included diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (manufacturer unknown), and haemophilus b conjugate vaccine (manufacturer unknown) (doses, lot numbers, and expiration dates were not provided. Concomitant therapy was not provided. The mother stated that 4-5 years ago, her son experienced seizures after receiving an unspecified pneumococcal vaccine. The mother reported that her son experienced multiple seizures at different times after receiving a dose of diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (manufacturer unknown); a dose of haemophilus b conjugate vaccine (manufacturer unknown); a dose of haemophilus b conjugate vaccine (manufacturer unknown); a dose of PC PNU vaccine (manufacturer unspecified), and a dose of 50 EBV vaccine (unspecified manufacturer). The mother also reported that her son also experienced odd behavior such as demonic ways, aggressiveness, and hallucinations after taking TAMIFLU on an unspecified date. At the time of the report, the patient outcome was unknown. Upon internal review, the event of seizures was considered to be medically significant. Additional information has been requested.
This spontaneous report as received from a physician via Pfizer, Inc. (MFR number 2014292668) refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of PNEUMOVAX23 (lot#, dose, route not reported). Concomitant therapies were not provided. The physician mentioned that the patient had been considered allergic or had a bad reaction with PNEUMOVAX23 on an unknown date. The outcome of the events were unknown. Additional information is not expected, since no additional health care professional contact details provided.
1 day p/vax felt like kicked inches on rt side;extreme sharp pain from front chest around rt side;labored breathing;T99.9, chills, generalized achiness, weakness, dizziness;chiropractic adjustment gave no relief;
Donor reported pain(4 out 10) and swelling at vaccine site(left arm) with local inflammation
I routinely check my blood pressure, as I'm being treated for hypertension. I happenned to take my blood pressure the evening following my booster dose.  At 9:30 at night my bp was 203/114. Alarmed, I checked it several times during the night when I happenned to be awake. It gradually decreased, but has remained somewhat elevated over my pre-booster readings and I have add Ramiphil to my medications.
I got a severe sore throat that started right away and my throat is swollen bad enough that it is hard to swallow
broke out in a rash on stomach, head & face;pt was also irritable;pt given DPH q 4hr;rash went away w/in 24hr;
Information has been received from a consumer concerning her daughter with allergies to corn, dairy soy and no reported medical history, who was vaccinated in "August 2005" (day unspecified) with the first dose of VARIVAX (Merck)  (route and lot number unspecified).  The mother reported that her daughter experienced "swelling or a big hive reaction on the injection site" after she received the second dose of VARIVAX (Merck) on 21-JUL-2009 (route and lot number unspecified).  There was no concomitant medication reported.  The mother stated the the patient never had reaction with the first dose of the vaccine.  No laboratory tests were performed.  At the time of the report the outcome was recovering.  The patient sought medical attention by calling the nurse.  Follow up information has been received from a nurse concerning a 5 year old female patient with multiple food allergies and asthma who on 21-JUL-2009 was vaccinated SQ into the right arm with a second dose of VARIVAX (Merck) (lot number : 663330/0493Y).  There was no illness at the time of vaccination.  On 22-JUL-2009, the patient developed a half dollar size area of redness.  The nurse reported that she gave her home care advice was given with instructions to see provided in 24 hours.  However the patient did not follow through.  At the time of the report the outcome of the patient was unknown.  Additional information has been requested.
face started feeling numb; good amount of pain in her arm; Arm was itchy around the site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by a physician and describes the occurrence of HYPOAESTHESIA (face started feeling numb), PAIN IN EXTREMITY (good amount of pain in her arm) and VACCINATION SITE PRURITUS (Arm was itchy around the site) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included Proair Inhaler, ortho tricyclin lo and Adderall IR for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (face started feeling numb), PAIN IN EXTREMITY (good amount of pain in her arm) and VACCINATION SITE PRURITUS (Arm was itchy around the site). At the time of the report, HYPOAESTHESIA (face started feeling numb), PAIN IN EXTREMITY (good amount of pain in her arm) and VACCINATION SITE PRURITUS (Arm was itchy around the site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (also had sore arm), INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERSOMNIA (just slept), PYREXIA (fever 103degF) and MYALGIA (body ache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (also had sore arm), INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERSOMNIA (just slept), PYREXIA (fever 103degF) and MYALGIA (body ache). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) for Fever, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (also had sore arm), INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERSOMNIA (just slept), PYREXIA (fever 103degF) and MYALGIA (body ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103 (High) 103degF.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Patient had the symptoms for 3 days.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: TCR was received and  reporter said that it was their son who has symptoms and requested to call back later.
When I caught Covid I had body aches, fever, coughing, sore throat, congestion in my head and chest, fatigue and a little diarrhea. I took OTC cough medicine, sinus decongestion, ibuprofen, and I rested.
EXPOSED TO DAUGHTER IN CAR FULLY VACCINATED SINCE 4/21 ONSET 8/4/21
Painful menstruation, debilitating. Severe pain, sharp cramps, heavy flow. Experienced similar with 2nd dose but not as severe.  Have never had severe cramping pain with periods until now. Will be speaking with my PCP tomorrow.
Hives, mild   resp. distress 20 minutes after vaccine. 50mg Benadryl given and sx subsided within 5 minutes,
received my 2nd shot at 9:24 AM on 01/17/21, Symptoms started 1/17/2021 @ 10:30 PM chills, muscles pain, fatigue, headache, fever, arm soreness around injection site as well as swollenness, symptoms subsided as of 01/19/21 around 11:30, 12 noonish
This report was received from Pfizer and was assigned manufacturer report number 2016342936 and 216343027 for PREVNAR, and refers to a 2 month old patient of unknown gender. Patient's pertinent medical history, drugs reactions/allergies and concomitant medication were not reported. On 06-JUL-2016, the reporter stated that the vaccine stayed in the fridge during all the period between 06-JUL-2016 and 10-JUL-2016. It was specified that on 06-JUL-2016, during a 24 hours period the maximum temperature of the fridge was 19 degrees. On 09-JUL-2016 the patient was vaccinated with an improperly storage ROTATEQ orally (strength, dosage schedule, lot # and expiration date were not reported). The reporter stated that, they would like to received information with evidence base data that showed the stability of the vaccine at room temperature and any information on whether they must kept the stock or dispose it. Additional information has been requested.
No negative effects on me. I had COVID-19 since then, no fever, deep cough, congestion, tightness upper part of my chest, a lot of flame collecting on bronchial tub. I had a COVID-19 test and it was positive. I contacted the doctor and he prescribed PAXLOVID, after 5 days I tested it was negative, but I had symptoms. so, I tested again, and it was positive.
HIVES AND RASH ON FACE, NECK, CHEST, BEHIND EARS, WHEEZING. GIVEN BENADRYL, SYMPTOMS RESOLVE UNTIL ANTIHISTAMINE WEARS OFF AND THEN HIVES COME BACK. DR DIAGNOSED SEVERE ALLERGIC REACTION.
A week after receiving the first injection I noticed a large, sensitive lump above my left clavicle. It would appear this is an inflamed lymph node, which I'm told is a somewhat common immune response to the vaccine.
Unconsolable crying for at least 3 hours within the first 48 hrs shots are given. 2 month shots given 8/13/2013.
Severe headache, rigors, high fever (subjective), tachycardia, severe nausea. Drenching sweats, "strange thoughts". Rigors and drenching sweats throughout the night.  "Crazy shaking fits." Presyncope.  Got to point where patient considered calling ambulance.  Lasted 12 hours then fully resolved.
Generalized joint pain that has continued until present. Needs high dose NSADS daily and still walks with a limp. 4/7/06 Review of medical records confirms diagnosis of idiopathic peripheral neuropathy. Initial symptoms included cough, fever, dizziness, and congestion since approximately 11/19/05. Temp was 104 for 3 days, diagnosed with bronchitis and treated with antibiotics. Diagnosed with pharyngitis, URI, cough, cerumen impaction, and dizziness.  4/27/06 Reviewed 3-page d/c summary. Diagnosis was non-organic pain syndrome, r/o conversion disorder. 60 Day Follow-up Information 20-JUN-2006: Still has difficulty running due to foot pains bilaterally. Functioning much better though. Follow-up: Service member deployed, unable to contact.
Dime size knot to L arm at site of infection.  Grew to approx. 3 inches diameter following date.
Ringing in ears (tinnitus) began the evening of April 6. I've never had this problem before.
Vaccine administered, 10 minutes later pt stated she felt dizzy. She did mention she was anxious after reading possible side effects of COVID vaccine. She started to cry and mentioned the recent loss of a family member. Five minutes later, stated she felt nauseous. Pt crying and requesting for us to call her sister. Denied chest pain, tightness of chest or trouble swallowing. Denied shortness of breath,
pt devel an erythematous papular rash on both ears; face & few on the neck; this occur 30 mins p/vax; DPH given;
Herpes zoster; Postherpetic Neuralgia.; Information has been received regarding a case in litigation regarding a male patient (pt) of unknown age. There was no information about the pt's concurrent conditions, medical history or concomitant medication.  On or around 11-SEP-2017, the pt was vaccinated zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (dose, route of administration, lot number and expiration date were not reported).  Shortly after receiving zoster vaccine live (ZOSTAVAX), the pt suffered herpes zoster and postherpetic neuralgia. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, the pt's symptoms resulted in physical limitations not presented prior to using the vaccine. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. The pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The pt suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was not reported.
headaches and fever everyday; headaches and fever everyday; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches and fever everyday) and PYREXIA (headaches and fever everyday) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031l20a and 002a21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced HEADACHE (headaches and fever everyday) and PYREXIA (headaches and fever everyday). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, HEADACHE (headaches and fever everyday) and PYREXIA (headaches and fever everyday) had not resolved. Not Provided          Concomitant medication Lipitor. & Blood pressure medication.
Developed hives on arms & chest a few hours after getting shot.  Gone in 12-14 hours.  Abdominal cramping & diarrhea 12-14 hours after getting shot.
Patients have been administered from vaccines that experienced a temperature excursion; Patients have been administered from vaccines that experienced a temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion). On 22-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Storage condition at the time of the excursion was reported as refrigerator. Maximum temperature reached was reported as 64°F. Excursion duration was reported as approximately 7 hours. Date vial moved from freezer to refrigerator was reported as unknown. They were returned to the refrigerator. No changes on visual inspection noting vaccine state. At the time they were unpunctured. The patient not had any adverse events post injection. The Tran date was reported as 23-Mar-2022.  No treatment information was reported.
pt recv vax that PM noticed erythema to dorsum lt 5th toe & lower extremity edema which resolved all by next AM x/erythema to 5th lt toe distally w/minimal erythema;blanched well w/good capillary refill;
Pt had the First Moderna Covid shot on  Nov  5 2021.     Symptoms started the same day.  Headache, Achyness, chills and dyspnea. on November 10, pt noted lower extremity  petechia,  and  lower extremity and soft palate bruising.   She came to the Emergency room on November 14th 2021,  She had a platlet count of 5000 on that day. She went home and  came back the next day with a platlet count of 4000. She was given IVIG and steriods , admitted and left the hospital on  November 17 th with a platlet count of 16000.    She came back and was admitted on the November 30th with  Platlet count of  7000, and I believe was DCed  with platlet count of 55000 She had no bruising  or petichia prior to  November  10th,  and   the last platlet count I have on her in the medical records was November 2019 and that was 166000  So normal at that time.
pain at injection site; redness at injection site; splotchy rash at injection site; splotchy rash at injection site; spastic colon; colitis; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd May 2019, the patient received the 1st dose of Shingrix (intramuscular). In May 2019, less than a week after receiving Shingrix, the patient experienced injection site pain, injection site erythema, injection site rash, macular rash, spastic colon and colitis. In May 2019, the outcome of the injection site pain, injection site erythema and injection site rash were recovered/resolved. On an unknown date, the outcome of the macular rash was recovered/resolved and the outcome of the spastic colon and colitis were unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site rash, macular rash, spastic colon and colitis to be related to Shingrix.  Additional details were provided as follows: The patient received 1st dose of Shingrix on left deltoid. One week after vaccination, the patient experienced what felt like spastic colon and colitis that had not resolved. Injection site pain, injection site erythema and injection site splotchy rash were lasted for 4 days. The patient had not seen the physician regarding this issue. The reporter consented to follow up.
Vaccine given too early.  First COVID vaccine was given on 12/20/20 and second dose was given on 01/04/21.  A difference of 14 days instead of the required 21 days for the Pfizer vaccine.  Patient has not reported any adverse events at this time due to the early administration of vaccine #2.
On 11/14/2022 I had a stress test completed and was scheduled for an angiogram. They noted that my artery was blocked 95%. I had to have 2 stents placed in my artery.
"Strain of rotator cuff capsule" - numbness in hand (recurring) - acute pain when raising left arm (continued).